ArticleMolecular biology reports2026
Effect of Glycosylphosphatidylinositol-specific phospholipase D1 knockout on the expression of antioxidant enzymes and sirtuin.
Article in Molecular biology reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundGlycosylphosphatidylinositol-specific phospholipase D1 (Gpld1) is a membrane-associated enzyme that modulates diverse cellular processes through the cleavage of glycosylphosphatidylinositol (GPI)-anchored proteins. Although recent studies have linked circulating Gpld1 to exercise-induced rejuvenation, its cell-autonomous role in coordinating redox homeostasis, melanogenesis, and cellular aging has not been fully elucidated. METHODS AND
resultsTo address this, a stable Gpld1 knockout (KO) was generated in B16F1 melanoma cells using CRISPR/Cas9-mediated genome editing to investigate whether loss of Gpld1 induces aging-associated phenotypes and redox imbalance. Gpld1 KO cells exhibited senescence-like features, as evidenced by increased senescence-associated β-galactosidase (SA-β-gal) activity, accompanied by disrupted redox homeostasis and markedly enhanced melanin synthesis. In the context of skin aging, hyperpigmentation often accompanies senescence-associated changes and thus represents a relevant phenotypic readout in this model. Gene and protein expression analyses revealed coordinated remodeling of multiple aging-associated signaling pathways. Specifically, SIRT1 and the redox repair enzyme MsrA were downregulated, whereas SIRT7, forkhead box O1 (FoxO1), phosphorylated FoxO1 (p-FoxO1), and Caspase-1 were markedly upregulated. Reduced steady-state reactive oxygen species (ROS) levels detected by 2',7'-dichlorodihydrofluorescein diacetate (DCFH-DA) likely reflect compensatory activation of antioxidant signaling pathways rather than the absence of oxidative stress.
conclusionCollectively, these findings demonstrate that Gpld1 KO induces Senescence-like features, alters redox homeostasis, and, in melanocytic cells, manifests as enhanced melanogenesis. These results identify Gpld1 as a previously unrecognized regulator of oxidative stress-driven aging and pigmentation, suggesting its potential relevance to aging-related hyperpigmentation and redox imbalance.
Indexed as
Identifiers
42579195What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.